Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Vertex Pharma (VRTX) Misses Q4 EPS by 8c, Revenues Beat; Provides FY21 Product Revenue Outlook
February 1, 2021 4:03 PM ESTVertex Pharma (NASDAQ: VRTX) reported Q4 EPS of $2.51, $0.08 worse than the analyst estimate of $2.59. Revenue for the quarter came in at $1.63 billion versus the consensus estimate of $1.58 billion.
"Our achievements in 2020 were marked by a significant increase in the number of... More
